European Patent Office honours exceptional inventors with European Inventor Award 2019
The European Patent Office (EPO) honoured exceptional inventors from Austria, France, Japan, the Netherlands and Spain with the European Inventor Award 2019 at a ceremony in Vienna. The laureates are recognised for their outstanding achievements in plastic recycling, cancer diagnostics, rechargeable battery technology, marine antifouling and DNA testing.

The winners of the European Inventor Award 2019 on stage at the award ceremony in Vienna on 20 June 2019, together with EPO President António Campinos, and Jury member Ursula Keller
European Patent Office
"The imagination, intellect and expertise on display at this year's European Inventor Award are inspirational; all of the finalists and winners are pushing boundaries and achieving new heights in their respective disciplines," said EPO President António Campinos at the Award ceremony. "These inventors' stories also show how patent protection can help turn innovation into market success. What's more, intellectual property rights are fuelling the European economy - industries that make high use of patents, trademarks and design rights contribute significantly to GDP, trade and job creation in Europe."
Held at the Wiener Stadthalle, the Award ceremony, now in its 14th edition, was attended by some 600 guests from the fields of intellectual property, politics, business, science and academia. The finalists and winners were selected by an independent, international jury from a pool of hundreds of inventors and teams of inventors put forward for this year's Award. The recipient of the Popular Prize was chosen by the general public through an online vote in the run-up to the ceremony.
The laureates of the European Inventor Award 2019
Industry
Klaus Feichtinger and Manfred Hackl (Austria): Higher-performance plastic recycling
By thinking in a new direction, these Austrian inventors reshaped plastic recycling. With their approach, waste plastics of many types can be turned into high quality pellets for new products. Today, more than 6 000 of their machines in operation worldwide produce over 14.5 million tonnes of plastic pellets annually.
Research
Jérôme Galon (France): Immunoscore®, a clearer cancer test
The French immunologist's diagnostic tool assesses the risk of relapse in cancer patients. It uses digital images of tumour samples and advanced software to measure immune response. Galon's invention is already in use at clinics around the world to improve the accuracy of prognosis for patients with colorectal cancer.
Non-EPO countries
Akira Yoshino (Japan): Lithium-ion battery and its evolution
This Japanese scientist is the father of the lithium-ion battery (LIB). His rechargeable batteries power nearly five billion mobile phones, laptops and other portable devices, as well as electric vehicles. For decades he has been dedicated to continually improving LIBs.
Small and medium-sized enterprises (SMEs)
Rik Breur (Netherlands): Marine antifouling fibre wrap
Inspired by a sea urchin's prickly surface, this Dutch inventor's antifouling fibre wrap is an environmentally friendly alternative to toxic paints on ships and marine structures. Algae, barnacles and mussels just slide off it, saving boats up to 40% on their fuel consumption.
Popular Prize and Lifetime achievement
Margarita Salas Falgueras (Spain): DNA amplification for genomics
The Spanish molecular genetics pioneer invented a faster, simpler and more reliable way to replicate traces of DNA into quantities large enough for full genomic testing, using the enzyme phi29 DNA polymerase. Her invention is now used widely in oncology, forensics and archaeology.
Most read news

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
A Trojan Horse delivery for treating a rare, potentially deadly, blood-clotting disorder - In this possible treatment, platelet blood cells carry an enzyme needed to prevent clots in TTP, while hiding the enzyme from autoantibody neutralization
CRELUX and ProQinase establish joint crystal-grade kinase protein and structures platform
Novel HCMV compound of AiCuris in phase IIb trial with bone marrow transplant recipients
Basilea receives milestone payment from distribution agreement for Toctino with Almirall
Biotage AB and McMaster University sign joint agreement to develop new chemistry platform
Asia-Pacific continues to drive global healthcare investment, innovation and growth ASEAN - A US$150 billion healthcare market by 2017, says Frost & Sullivan
Pharmacogenomics study finds rare gene variants critical for personalized drug treatment

Cambridge-based Startup Develops World’s Fastest Coronavirus-Killing Antiviral Protection
Evolva shareholders approve all Board proposals in AGM: Green light for Abunda acquisition
Aragen Bioscience, Inc. and CEVEC Sign License Agreement for Human CAP and CAP-T Technology
